Granulomatous Disease, Chronic - 24 Studies Found
Recruiting |
: Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995 : Granulomatous Disease, Chronic : 2014-03-06 |
Terminated |
: Gene Therapy for Chronic Granulomatous Disease : Chronic Granulomatous Disease : 2006-10-31 : Drug: Phagocyte Oxidase Subunit Transduced CD34 Hematopoietic Stem Cells |
Recruiting |
: Study of Gene Therapy Using a Lentiviral Vector to Treat X-linked Chronic Granulomatous Disease : Granulomatous Disease, Chronic, X-linked : 2014-09-04 : Biological: Lentiviral G1XCGD Gene Therapy The investigati |
Withdrawn |
: Lentiviral Gene Therapy for X-Linked Chronic Granulomatous Disease (X-CGD) : Granulomatous Disease, Chronic, X-linked, Variant : 2011-06-23 : Genetic: pCCLchimGp91s lentiviral vector transduced CD34+ cells infusion pCCLchimGp91s lentiviral vector |
Completed |
: Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) in Children : Chronic Granulomatous Disease : 2009-06-22 : Genetic: retroviral SF71-gp91phox transduced CD34+ cells autologous ex-vivo transduced (SF71-gp91phox)CD |
Recruiting |
: Generation of Powerful Biological Tools for Understanding the Pathophysiology of Chronic Granulomatous Disease. : Chronic Granulomatous Disease : 2016-10-04 : Other: samples collection : hair and skin biopsy |
Active, not recruiting |
: Gene Therapy for Chronic Granulomatous Disease in Korea : Chronic Granulomatous Disease : 2008-10-21 : Drug: VM106 Autologous hematopoietic stem cells with MT-gp91 retroviral vector |
Not yet recruiting |
: Pioglitazone Therapy for Chronic Granulomatous Disease : Chronic Granulomatous Disease : 2017-02-27 : Drug: Pioglitazone Pioglitazone is PPARγ agonist that |
Recruiting |
: Matched Unrelated or Non-Genotype Identical Related Donor Transplantation For Chronic Granulomatous Disease : Chronic Granulomatous Disease : 2007-12-19 :
|
Completed |
: Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of Care : Chronic Granulomatous Disease : 2001-08-29 : Drug: T-Cell Depleted & CD34+Select/w/StemCell Enriched Product |